COMPOSITIONS THAT MODULATE COMPLEMENT FACTOR B AND METHODS OF USE THEREOF - Patent application

JP2024541771A5Pending Publication Date: 2026-06-15ADARX PHARMACEUTICALS INC

Patent Information

Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
ADARX PHARMACEUTICALS INC
Filing Date
2022-11-23
Publication Date
2026-06-15
Patent Text Reader

Abstract

Aspects of the present disclosure provide compounds, compositions and methods for modulating the expression or activity of complement factor B (CFB). In certain aspects, the compounds, compositions and methods of the present disclosure can be used to reduce the expression of CFB mRNA in a cell or animal. In certain aspects, the compounds, compositions and methods of the present disclosure can be used to reduce the expression of CFB protein in a cell or animal. In certain embodiments, the animal has or is at risk for a complement pathway-related disease, disorder or condition, or a symptom thereof.
Need to check novelty before this filing date? Find Prior Art